If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Study for people with Heart Disease

Recruiting Not a phased study

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Not a phased study
Sponsor Capstan Medical
Registry number NCT06600191
Started 24 February 2025 Today 16 October 2026 Estimated completion 1 December 2026

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Monash Health, Victorian Heart Hospital Melbourne Australia Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 10

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Age ≥ 18 years at the time of consent.

* Moderate-severe (3+) or severe (4+) mitral regurgitation

* NYHA II or greater symptoms despite optimal medical treatment.

* The local multi-disciplinary heart team agrees that TMVR is the preferred treatment over surgical intervention or other available treatment options (such as TEER).

* Ability and willingness to provide written informed consent prior to any study related procedure(s).

Exclusion Criteria:

* LVEF less than 20%

* Anatomic features (e.g., annular dimensions, neo-LVOT area, transfemoral and transseptal access, excessive MAC) unsuitable for the Capstan System

* Severe aortic valve stenosis or regurgitation

* Severe mitral stenosis

* Severe right ventricular dysfunction or severe tricuspid valve disease

* Evidence of intracardiac thrombus, vegetation, or mass

* Prior mitral valve intervention that would interfere with the appropriate placement of the Capstan Valve

* Any percutaneous coronary, carotid, or other endovascular intervention within 30 days prior to procedure

* Myocardial infarction within 30 days prior to procedure

* Cardiac resynchronization therapy (CRT) device implanted within 30 days of procedure

* Active endocarditis, other ongoing infection requiring antibiotic therapy

* Stroke or transient ischemic attack (TIA) within 30 days of procedure

* Active peptic ulcer or active gastrointestinal bleeding

* Severe pulmonary arterial hypertension with fixed PASP greater than 85mmHg

* End-stage renal failure on dialysis

* Life expectancy less than 1 year

* Subject is on the waiting list for a heart transplant or has had a prior heart transplant

* Pregnant (Participants of childbearing age are required to have a negative pregnancy test).

* Known allergy to antiplatelet therapy, heparin, or to device materials

* Inability to tolerate anticoagulation or antiplatelet therapies

* Absence of appropriate venous access

* Unable to have transesophageal echocardiography

* Unwillingness to complete the required follow-up visits

Dates on the record

Started 24 February 2025
Estimated completion 1 December 2026
Registry last updated 28 August 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 28 August 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.